[HTML][HTML] Circulating tumor cells as a tool for assessing tumor heterogeneity
M Tellez-Gabriel, MF Heymann, D Heymann - Theranostics, 2019 - ncbi.nlm.nih.gov
Tumor heterogeneity is the major cause of failure in cancer prognosis and prediction.
Accurately detecting heterogeneity for the development of biomarkers and the detection of …
Accurately detecting heterogeneity for the development of biomarkers and the detection of …
[HTML][HTML] Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study
C Tesauro, AK Simonsen, MB Andersen, KW Petersen… - BMC cancer, 2019 - Springer
Background Camptothecin (CPT) and its derivatives are currently used as second-or third-
line treatment for patients with endocrine-resistant breast cancer (BC). These drugs convert …
line treatment for patients with endocrine-resistant breast cancer (BC). These drugs convert …
[HTML][HTML] Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms-a single-center retrospective study
H Shi, Q Zhang, C Han, D Zhen, R Lin - BMC endocrine disorders, 2018 - Springer
Abstract Background The Ki-67 index in gastroenteropancreatic neuroendocrine neoplasms
(GEP-NENs) may change throughout the disease course. However, the definitive effect of Ki …
(GEP-NENs) may change throughout the disease course. However, the definitive effect of Ki …
[HTML][HTML] Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance
X Hu, W Chen, F Li, P Ren, H Wu, C Zhang… - Frontiers in …, 2023 - frontiersin.org
Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …
Natural history of invasive papillary breast carcinoma followed for 10 years: a case report and literature review
YJ Suh, H Shin, TJ Kwon - Case Reports in Medicine, 2017 - Wiley Online Library
Diachronic research on untreated breast cancer completely depends on past medical
records when no more recent, advanced methods are available. Herein, we report a case of …
records when no more recent, advanced methods are available. Herein, we report a case of …
[PDF][PDF] The TP53-R72P (rs1042522) polymorphism and risk factors in breast cancer patients
MR Lisboa, BC de Almeida… - Eur. J …, 2018 - venus-pro-bucket.s3.amazonaws …
The authors aimed to assess the incidence of TP53-R72P polymorphism correlating with risk
factors and clinical-pathological features in breast cancer (BC). Genotypic distribution was …
factors and clinical-pathological features in breast cancer (BC). Genotypic distribution was …